Fundraising Fox

Catherine Pickering

Founder

Co-Founder & CEO at iOnctura

Geneva, Geneva, Switzerland

FoundediOnctura

About

Catherine Pickering is CEO and Co-Founder of iOnctura SA, a Swiss-Dutch clinical-stage biopharmaceutical company developing therapies for hard-to-treat cancers, which she founded in 2017 and has grown to more than 15 team members. Since the company's inception, she has raised over €100M in private financing, advanced two programs into mid-stage clinical development, and in-licensed an additional small molecule program. Before founding iOnctura, she led global oncology and immuno-oncology licensing and business development at Merck KGaA, and she holds a PhD in Medicinal Chemistry from the Institute of Cancer Research and an MBA from Henley Business School.

Co-Founder & CEO at iOnctura

Intro paths

→

In turn, Catherine can intro founders to iOnctura's investors below.

iOnctura's investors · 6

3B Future Health FundMonaco · $12M checksInkefAmsterdamM VenturesLos Angeles · $10.8M checksSynconaLondonVI PartnersAltendorf · $2.2M – $4.5M checksXGEN VentureMilan

Co-founders at iOnctura

LVLars van der Veen
Lars van der VeenCo-Founder & CSO

Experience

  1. iOnctura SACEO & Foundercurrent2017 — presentGeneva Area, Switzerland
  2. iOnctura SAChief Executive Officercurrent2017 — present
  3. Merck SeronoHead of Oncology Licensing, Global Business Development2011 — 2017Geneva
  4. Merck SeronoDirector of Business Development2006 — 2011
  5. Antisoma PLCLicensing and Alliance Manager2004 — 2006
  6. The Institute of Cancer ResearchBusiness Development Manager2001 — 2004

Skills & more

Leadership5Strategy6Clinical Development24Biotechnology27Technology Transfer27Licensing18Pharmaceutical Industry21Pharmaceutics4Oncology30Regulatory Affairs3GCP1Global Business Development4
+12 moreDrug DiscoveryClinical ResearchBusiness DevelopmentMarketing StrategyMarket AccessBiopharmaceuticalsCROCommercializationDrug DevelopmentR&DClinical TrialsBusiness Strategy

From Catherine's professional profile.

Frequently asked questions

Who is Catherine Pickering?
Catherine Pickering is CEO and Co-Founder of iOnctura SA, a Swiss-Dutch clinical-stage biopharmaceutical company developing therapies for hard-to-treat cancers, which she founded in 2017 and has grown to more than 15 team members. Since the company's inception, she has raised over €100M in private financing, advanced two programs into mid-stage clinical development, and in-licensed an additional small molecule program. Before founding iOnctura, she led global oncology and immuno-oncology licensing and business development at Merck KGaA, and she holds a PhD in Medicinal Chemistry from the Institute of Cancer Research and an MBA from Henley Business School.
Where does Catherine Pickering work?
Catherine Pickering is Co-Founder & CEO of iOnctura.
What companies did Catherine Pickering found?
Catherine Pickering founded iOnctura.
Where did Catherine Pickering go to school?
Catherine Pickering studied at Henley Business School (Master of Business Administration (MBA)); The Institute of Cancer Research (Doctor of Philosophy (PhD), Medicinal and Pharmaceutical Chemistry).

Are you in our directory? — or find your own page and tap it there to see your paths to every investor.

Founder mafias

Henley Business School mafia12

Also came through, then founded or led a company.

Khatereh AhmadiExecutive MBAFounded ReViralMark CarpenterMBAFounded Dayton SuperiorFred PLAISCompleted year 1 of the Henley MBA programFounded Platform ShRichard PrimeBusiness Leaders ProgrammeFounded SonovateChristopher JaneFinance & Investment BankingFounded Proper GoodTimothy BrownstoneFellowFounded Kymira

+ 5 more

The Institute of Cancer Research mafia3

Also came through, then founded or led a company.

Elizabeth IornsPh.D.Founded Transcripta Bio +1Elisabet de los PinosMolecular BiologyFounded Aura Biosciences

Same school

Also attended Henley Business School62

John HortonInvestor at DN CapitalIrene ArdenstedtInvestor at Luminar VenturesCharles VasletSenior Partner, Chief Revenue Officer at Emerald Technology Ventures AgSanne van ErpInvestment manager at NoaberKieran MudryyPartner at 4BIO CapitalJames ChapmanEntrepreneur in Residence at Cambridge Innovation Capital

+ 56 more

Also attended The Institute of Cancer Research3

Marc-Olivier TurgeonSenior Associate at ForbionElizabeth IornsAngelElisabet de los PinosFounder at Aura Biosciences

Shared employers

Also worked at iOnctura SA8

Raghd RostomInvestor at SynconaDiego BragugliaManaging Partner at VI PartnersKeno GutierrezGeneral Partner at BioGeneration VenturesHakan GokerManaging Director at M VenturesThijs Cohen TervaertPartner at InkefPaolo FundaròFounder and Managing Partner at XGEN Venture

+ 2 more

Also worked at Merck Serono19

Giovanni MariggiInvestor at MedicxiRoel BulthuisInvestor at SynconaMathias FalcenbergVenture Partner at V-Bio VenturesParis PanayiotopoulosSenior Managing Director at Blackstone Life SciencesFrederic WohlwendManaging Partner at Forestay CapitalAlicia Irurzun-LafittePartner at UCB Ventures

+ 13 more

Also worked at Antisoma PLC1

George SyrmalisDr at Bioscience Equity Partners

Also worked at The Institute of Cancer Research12

Charles GrummittInvestor at MedicxiMelina HoffmannInvestor at SynconaHakan GokerManaging Director at M VenturesPedro GuerraPartner at Civeta InvestmentMira AndroniciucInvestment Associate at DSW VenturesSabila ChilaevaAssociate at Ahren Innovation Capital

+ 6 more